FDA To Review Safety of Weight Loss Drug Meridia
Nov 24th, 2009 | By admin | Category: Featured, Weight LossThe FDA’s initial findings on its review of the weight loss drug Meridia should give pause to some patients, particularly those who are overweight and may have heart problems.
The recent study tested Meridia (sibutramine) in overweight or obese people with an increased risk for heart problems. The agency warned that doctors and their patients should follow the current guidelines, which recommend against using Meridia in people with a history of coronary artery disease, congestive heart failure, heart rhythms disorders called arrhythmias, or stroke.
The FDA will continue to review findings from the SCOUT study, which was designed to test whether Meridia could help prevent heart problems by helping overweight and obese people lose weight. The FDA isn’t making any conclusions about the early findings at this time. Analysis of the study’s findings is ongoing.
The study in question was a European one in which 10,000 people aged 55 years or older with a history of heart disease or type 2 diabetes were given Meridia (or a placebo) for five years.
Source: WebMD
Popularity: 2% [?]
